Active selexipag-metabolite MRE-269 induces DUSP1 and inhibits PASMC proliferation

Back

ESC Premium Access

Active selexipag-metabolite MRE-269 induces DUSP1 and inhibits PASMC proliferation

Session: Poster Session 4 - Acute and chronic pulmonary hypertension : treatment

Topic: Pathophysiology and Mechanisms

Speaker: Doctor H. Maruyama (Tsuchiura, JP)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Hidekazu Maruyama

National Hospital Organization Kasumigaura Medical Center, Tsuchiura (Japan)

1 presentation

0 follower

9 more presentations in this session

Efficacy and safety of direct oral anticoagulants in intermediate-high risk pulmonary embolism: results from a multidisciplinary multicenter prospective registry

Speaker: Doctor R. Chopard (Besancon, FR)

Access

Abstract

Non-recommended dosing of direct oral anticoagulants in acute pulmonary embolism is related to an increased rate of adverse events at 6 months: results of a prospective regional multicenter registry

Speaker: Doctor G. Serzian (Besancon, FR)

Access

Abstract

Extracorporeal membrane oxygenation in patients with pulmonary embolism

Speaker: Professor N. Meneveau (Besancon, FR)

Access

Abstract

Slides

Transthoracic pulmonary artery denervation attenuates the progression of pulmonary arterial hypertension in a rat model

Speaker: Doctor Y. Huang (Beijing, CN)

Access

Abstract

Slides

Comparison of cardiac output measurement methods for mortality prediction in pulmonary hypertension

Speaker: Doctor E. Simsek (Izmir, TR)

Access

Abstract

Slides

Access the full session

Poster Session 4 - Acute and chronic pulmonary hypertension : treatment

Speakers: Doctor H. Maruyama, Doctor R. Chopard, Doctor G. Serzian, Professor N. Meneveau, Doctor Y. Huang...

Access

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources